Pierre Vereecken
Overview
Explore the profile of Pierre Vereecken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vereecken P, Cornelis F, van Baren N, Vandersleyen V, Baurain J
Dermatol Res Pract
. 2012 Jan;
2012:260643.
PMID: 22287956
Many serum biomarkers have been evaluated in melanoma but their clinical significance remains a matter of debate. In this paper, a review of the serum biomarkers for melanoma will be...
2.
Janik M, Litynska A, Vereecken P
Biochim Biophys Acta
. 2010 Mar;
1800(6):545-55.
PMID: 20332015
Background: Cell migration is an essential process in organ homeostasis, in inflammation, and also in metastasis, the main cause of death from cancer. The extracellular matrix (ECM) serves as the...
3.
Vereecken P, Awada A, Suciu S, Castro G, Morandini R, Litynska A, et al.
Melanoma Res
. 2009 Jul;
19(5):316-20.
PMID: 19581819
Galectin-3 (Gal-3) is a member of the beta-galactoside-binding lectins family and has been implicated in angiogenesis, tumor invasion, and metastatic process in vitro and in vivo. As we showed recently...
4.
Pirard D, Bellens B, Vereecken P
Dermatol Online J
. 2008 Jul;
14(3):13.
PMID: 18627714
The incidence of the post-thrombotic syndrome (PTS) is increasing along with the incidence of deep vein thrombosis (DVT). The overall frequency of PTS ranges from 20 percent to 50 percent...
5.
Steels E, Peretz A, Vereecken P
J Dermatolog Treat
. 2008 Jul;
20(1):59-60.
PMID: 18608731
No abstract available.
6.
Henness S, Vereecken P
Curr Opin Oncol
. 2008 Apr;
20(3):280-6.
PMID: 18391627
(1) Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer of neuroendocrine origin generally seen in patients over 50 years of age. It has a high propensity for recurrence...
7.
Vereecken P, Awada A, Ghanem G, Marques da Costa C, Larsimont D, Simoens C, et al.
Med Sci Monit
. 2007 May;
13(6):CS75-7.
PMID: 17534239
Background: Extramammary Paget's disease (EMPD) is a rare skin disease which can be limited to the epidermis and can sometimes also be associated with underlying carcinomas. At clinical examination, lesions...
8.
Vereecken P, Laporte M, Heenen M
J Cutan Pathol
. 2007 Jan;
34(2):139-45.
PMID: 17244025
Malignant melanoma has been extensively studied concerning methods of predicting progression and clinical outcome. The maximum tumor thickness as measured by Breslow's method is the cornerstone prognostic criterion, but despite...
9.
Vereecken P, Heenen M, Babar S, van Baren N
J Eur Acad Dermatol Venereol
. 2007 Jan;
21(2):278-80.
PMID: 17243984
No abstract available.
10.
Kasper B, DHondt V, Vereecken P, Awada A
Crit Rev Oncol Hematol
. 2007 Jan;
62(1):16-22.
PMID: 17208006
Malignant melanoma is one of the most common cancer types among the Caucasian population. While the prognosis is excellent for patients diagnosed at an early stage and treated by adequate...